Successful interferon-alpha 2b therapy for unremitting warts in a patient with DOCK8 deficiency

Clinical Immunology

Volumn 153, Issue 1, 2014, Pages 104-108

  Al Zahrani, Daifulah ^a   Raddadi, Ali ^a   Massaad, Michel ^b   Keles, Sevgi ^b   Jabara, Haifa H ^b   Chatila, Talal A ^b   Geha, Raif ^b  

^a KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

DOCK8 deficiency; Hyper immunoglobulin E syndrome; Interferon 2b; Papilloma virus; Warts

Indexed keywords

ALPHA INTERFERON; ALPHA2B INTERFERON; ANTIBIOTIC AGENT; CIMETIDINE; DEDICATOR OF CYTOKINESIS 8 PROTEIN; IMMUNOGLOBULIN E; MEASLES MUMPS RUBELLA VACCINE; PEGINTERFERON ALPHA2B; PNEUMOCOCCUS VACCINE; PROTEIN; UNCLASSIFIED DRUG;

ANAPHYLAXIS; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; B LYMPHOCYTE; CASE REPORT; CELL LYSATE; CHICKENPOX; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; CRYOTHERAPY; CYTOKINE PRODUCTION; DEDICATOR OF CYTOKINESIS 8 DEFICIENCY; DISEASE SEVERITY; DRUG TREATMENT FAILURE; EOSINOPHILIA; FLOW CYTOMETRY; FOOD ALLERGY; GENE MUTATION; HOSPITALIZATION; HUMAN; HUMAN CELL; HYPERGAMMAGLOBULINEMIA; IMMUNIZATION; IMMUNOBLOTTING; IMMUNOGLOBULIN BLOOD LEVEL; INTRON; LYMPHOCYTE COUNT; LYMPHOCYTOPENIA; MALE; MOLLUSCUM CONTAGIOSUM; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMACYTOID DENDRITIC CELL; POLYMERASE CHAIN REACTION; PRICK TEST; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; RECURRENT DISEASE; SCHOOL CHILD; SEPSIS; SEQUENCE ANALYSIS; SINGLE DRUG DOSE; SKIN ABSCESS; SKIN TEST; SPLICING DEFECT; SUPPURATIVE OTITIS MEDIA; TREATMENT RESPONSE; VERRUCA VULGARIS;

DOCK8 DEFICIENCY; HYPER -IMMUNOGLOBULIN E SYNDROME; INTERFERON-Α 2B; PAPILLOMA VIRUS; WARTS;

CHILD; DNA MUTATIONAL ANALYSIS; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOPHENOTYPING; INTERFERON-ALPHA; JOB SYNDROME; LEUKOCYTES, MONONUCLEAR; MALE; MUTATION; PEDIGREE; RECOMBINANT PROTEINS; SKIN; WARTS;

EID: 84899692269     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2014.04.005     Document Type: Article

References (15)

1. Engelhardt K.R., McGhee S., Winkler S., Sassi A., Woellner C., Lopez-Herrera G., Chen A., Kim H.S., Lloret M.G., Schulze I., Ehl S., Thiel J., Pfeifer D., Veelken H., Niehues T., Siepermann K., Weinspach S., Reisli I., Keles S., Genel F., Kutukculer N., Camcioglu Y., Somer A., Karakoc-Aydiner E., Barlan I., Gennery A., Metin A., Degerliyurt A., Pietrogrande M.C., Yeganeh M., Baz Z., Al-Tamemi S., Klein C., Puck J.M., Holland S.M., McCabe E.R., Grimbacher B., Chatila T.A. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J. Allergy Clin. Immunol. 2009, 124:1289-1302. (e1284).
2. Zhang Q., Davis J.C., Lamborn I.T., Freeman A.F., Jing H., Favreau A.J., Matthews H.F., Davis J., Turner M.L., Uzel G., Holland S.M., Su H.C. Combined immunodeficiency associated with DOCK8 mutations. N. Engl. J. Med. 2009, 361:2046-2055.
3. Chu E.Y., Freeman A.F., Jing H., Cowen E.W., Davis J., Su H.C., Holland S.M., Turner M.L. Cutaneous manifestations of DOCK8 deficiency syndrome. Arch. Dermatol. 2012, 148:79-84.
4. Jabara H.H., McDonald D.R., Janssen E., Massaad M.J., Ramesh N., Borzutzky A., Rauter I., Benson H., Schneider L., Baxi S., Recher M., Notarangelo L.D., Wakim R., Dbaibo G., Dasouki M., Al-Herz W., Barlan I., Baris S., Kutukculer N., Ochs H.D., Plebani A., Kanariou M., Lefranc G., Reisli I., Fitzgerald K.A., Golenbock D., Manis J., Keles S., Ceja R., Chatila T.A., Geha R.S. DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation. Nat. Immunol. 2012, 13:612-620.
5. Reizis B., Bunin A., Ghosh H.S., Lewis K.L., Sisirak V. Plasmacytoid dendritic cells: recent progress and open questions. Annu. Rev. Immunol. 2011, 29:163-183.
6. Ito T., Kanzler H., Duramad O., Cao W., Liu Y.J. Specialization, kinetics, and repertoire of type 1 interferon responses by human plasmacytoid predendritic cells. Blood 2006, 107:2423-2431.
7. Leventhal B.G., Kashima H.K., Mounts P., Thurmond L., Chapman S., Buckley S., Wold D. Long-term response of recurrent respiratory papillomatosis to treatment with lymphoblastoid interferon alfa-N1. Papilloma Study Group. N. Engl. J. Med. 1991, 325:613-617.
8. Keles S., Jabara H.H., Reisli R., McDonald D.R., Barlan I., Hanna-Wakim R., Dbaibo R., Lefranc R., Al-Herz W., Geha R.S., Chatila T.A. Plasmacytoid dendritic cell depletion in DOCK8 deficiency: rescue of severe herpetic infections with interferon alpha-2b therapy. J. Allergy Clin. Immunol. 2014, (in press).
9. Gotoh K., Tanaka Y., Nishikimi A., Inayoshi A., Enjoji M., Takayanagi R., Sasazuki T., Fukui Y. Differential requirement for DOCK2 in migration of plasmacytoid dendritic cells versus myeloid dendritic cells. Blood 2008, 111:2973-2976.
10. Gotoh K., Tanaka Y., Nishikimi A., Nakamura R., Yamada H., Maeda N., Ishikawa T., Hoshino K., Uruno T., Cao Q., Higashi S., Kawaguchi Y., Enjoji M., Takayanagi R., Kaisho T., Yoshikai Y., Fukui Y. Selective control of type I IFN induction by the Rac activator DOCK2 during TLR-mediated plasmacytoid dendritic cell activation. J. Exp. Med. 2010, 207:721-730.
11. Harada Y., Tanaka Y., Terasawa M., Pieczyk M., Habiro K., Katakai T., Hanawa-Suetsugu K., Kukimoto-Niino M., Nishizaki T., Shirouzu M., Duan X., Uruno T., Nishikimi A., Sanematsu F., Yokoyama S., Stein J.V., Kinashi T., Fukui Y. DOCK8 is a Cdc42 activator critical for interstitial dendritic cell migration during immune responses. Blood 2012, 119:4451-4461.
12. Crawford G., Enders A., Gileadi U., Stankovic S., Zhang Q., Lambe T., Crockford T.L., Lockstone H.E., Freeman A., Arkwright P.D., Smart J.M., Ma C.S., Tangye S.G., Goodnow C.C., Cerundolo V., Godfrey D.I., Su H.C., Randall K.L., Cornall R.J. DOCK8 is critical for the survival and function of NKT cells. Blood 2013, 122:2052-2061.
13. Randall K.L., Chan S.S., Ma C.S., Fung I., Mei Y., Yabas M., Tan A., Arkwright P.D., Al Suwairi W., Lugo Reyes S.O., Yamazaki-Nakashimada M.A., Garcia-Cruz Mde L., Smart J.M., Picard C., Okada S., Jouanguy E., Casanova J.L., Lambe T., Cornall R.J., Russell S., Oliaro J., Tangye S.G., Bertram E.M., Goodnow C.C. DOCK8 deficiency impairs CD8 T cell survival and function in humans and mice. J. Exp. Med. 2011, 208:2305-2320.
14. Mizesko M.C., Banerjee P.P., Monaco-Shawver L., Mace E.M., Bernal W.E., Sawalle-Belohradsky J., Belohradsky B.H., Heinz V., Freeman A.F., Sullivan K.E., Holland S.M., Torgerson T.R., Al-Herz W., Chou J., Hanson I.C., Albert M.H., Geha R.S., Renner E.D., Orange J.S. Defective actin accumulation impairs human natural killer cell function in patients with dedicator of cytokinesis 8 deficiency. J. Allergy Clin. Immunol. 2013, 131:840-848.
15. Gatz S.A., Benninghoff U., Schutz C., Schulz A., Honig M., Pannicke U., Holzmann K.H., Schwarz K., Friedrich W. Curative treatment of autosomal-recessive hyper-IgE syndrome by hematopoietic cell transplantation. Bone Marrow Transplant. 2011, 46:552-556.